Medtronic
Medtronic plc (NYSE: MDT) is a global medical technology company founded in 1949 that designs, manufactures, and sells devices across cardiovascular, surgical robotics, neurovascular, and neuromodulation therapy areas, serving hospitals, healthcare systems, and ambulatory surgery centers across 150+ countries.
- Company typePublic
- Founded1949
- HeadquartersMinneapolis, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Medtronic does
Medtronic plc (NYSE: MDT; incorporated in Ireland; operational hub in Minneapolis) is a global medical technology company founded in 1949 that designs, manufactures, and sells devices across cardiovascular, surgical robotics, neurovascular, diabetes (now spun off as MiniMed), and neuromodulation therapy areas. The company operates across more than 150 countries, addressing roughly 70 health conditions, with a product portfolio that includes the Hugo Robotic-Assisted Surgery system (FDA-cleared for urologic procedures in December 2025 with 510(k) submissions pending for general and gynecologic surgery), the PulseSelect Pulsed Field Ablation system (first PFA technology approved in the U.S.), the Affera cardiac mapping and ablation system, the Stealth AXiS surgical navigation platform, the Nellcor pulse oximetry system with Nell-EQ intelligent processor, the Symplicity Spyral renal denervation system, and the Scientia Vascular neurovascular access product line acquired in June 2026.
The company generates revenue primarily through direct hospital sales of medical device hardware and capital equipment (including recurring consumables, accessories, and software licenses tied to installed platforms), supplemented by professional services and channel-based distribution partnerships (e.g., exclusive U.S. distribution for Corsano Health wearables; Western Europe distribution for Retia Medical's Argos monitor). Pricing is negotiated via multi-year hospital procurement contracts and Group Purchasing Organization (GPO) agreements; no consumer-facing pricing is published. Revenue model is hardware-led, with Q4 FY2026 revenue of $9.807 billion and full-year FY2026 revenue of $36.364 billion (up 8.4% YoY).
The go-to-motion combines a direct enterprise field sales organization targeting hospitals, health systems, and ambulatory surgery centers with regional channel partnerships and an active bolt-on M&A program ($550M Scientia Vascular, up to $585M CathWorks, $650M SPR Therapeutics). The customer base spans primary hospitals and healthcare systems, specialist physicians (cardiologists, electrophysiologists, neurosurgeons, interventional radiologists), and emerging remote/home healthcare segments. FY2027 organic revenue growth guidance is 5.5%-6.0%, with the company maintaining 49 consecutive years of dividend increases and an A S&P credit rating.
Medtronic firmographics
Firmographics- Name
- Medtronic
- Legal name
- Medtronic plc
- Website
- https://medtronic.com
- Company type
- Public
- Founded year
- 1949
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Medtronic plc (NYSE: MDT) is a global medical technology company founded in 1949 that designs, manufactures, and sells devices across cardiovascular, surgical robotics, neurovascular, and neuromodulation therapy areas, serving hospitals, healthcare systems, and ambulatory surgery centers across 150+ countries.
- Ownership category
- akta.pro rank
Medtronic industry classification
Industry- Product category
- Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
Keywords
Where Medtronic is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Medtronic business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations
Revenue model
- Medical Device Hardware Sales: Medtronic generates the majority of revenue through selling medical devices and hardware including cardiovascular implants, surgical robots, monitoring systems, and neurovascular products. Revenue is generated through direct hospital sales, distribution partnerships, and recurring device placements.
- Diabetes Care Products: Following the MiniMed IPO during fiscal 2026, the diabetes business operates as a standalone publicly traded entity (MMED), with Medtronic retaining an ongoing interest in continuous glucose monitoring systems and insulin delivery devices.
- Surgical Systems and Accessories: Capital equipment sales of surgical robotic systems including Hugo RAS, along with recurring revenue from proprietary consumables, accessories, and software licenses tied to those platforms.
- Service and Support: Professional services, training, and support services associated with medical device deployment and ongoing clinical utilization.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Medical devices and capital equipment sold via direct enterprise contracts with healthcare systems |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Medtronic product offering
Product offeringCore offering
Medtronic designs, manufactures, and sells medical devices and capital equipment across cardiovascular, surgical robotics, neurovascular, neuromodulation, and diabetes therapy areas. Its portfolio includes robotic-assisted surgery systems (Hugo RAS), pulsed field ablation systems (PulseSelect), renal denervation systems (Symplicity Spyral), surgical navigation platforms (Stealth AXiS), pulse oximetry systems (Nellcor), and cardiac mapping/ablation systems (Affera), sold primarily to hospitals, healthcare systems, and ambulatory surgery centers worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- MiniMed: Diabetes care business that was spun off as a standalone publicly traded entity during fiscal 2026
- Hugo
- PulseSelect
- Scientia Vascular
Products and services
- Hugo Robotic-Assisted Surgery System
- PulseSelect Pulsed Field Ablation (PFA) System
- Nellcor Pulse Oximetry System with Nell-EQ Intelligent Processor
- Stealth AXiS Surgical System
- Symplicity Spyral Renal Denervation System
- Affera Mapping and Ablation System
- Diabetes Care Products (MiniMed spin-off)
- Scientia Vascular Neurovascular Access Products
Quantifiable outcome
- 78% Cardiac Ablation Solutions revenue growth in Q4 FY26, with 124% U.S. growth, reaching over $2 billion annualized
- +4 more outcomes
Companies that use Medtronic
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Medtronic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability4 records
Feature6 records
Medtronic partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and strategic.
- Karl StorzcoreCollaboration with Karl Storz to enhance ENT offerings. Medtronic received CE mark for Stealth AXiS surgical system for ENT procedures, establishing collaboration to integrate Karl Storz's exoscope technology with Medtronic's navigation and robotic platforms.
- Retia MedicalcoreExpanded commercial relationship to distribute Argos Cardiac Output Monitor across Western Europe. Argos uses Multi-Beat Analysis technology developed at MIT and Michigan State University, providing hemodynamic data across ten parameters without requiring calibration. First entry into European markets for Retia Medical through Medtronic's established distribution network.
- Corsano HealthcoreExclusive U.S. distribution agreement for Corsano's multi-parameter wearable device monitoring heart rate, SpO2, respiratory rate, skin temperature, and activity data. Expands Medtronic's Acute Care & Monitoring portfolio into wrist-worn form factor for hospital and hospital-to-home use. Builds on prior Western Europe distribution agreement.
- Beluga MedicalstrategicStrategic investment to develop intracardiac echocardiography (ICE) catheter technologies for integration into the Affera mapping and ablation system. Beluga Medical is a pre-market stage company based in California developing ICE technology for cardiac ablation procedures.
- CardioACCstrategicStrategic investment in early commercial-stage company based in Shenzhen, China that received NMPA approval for its ICE system in 2025. Investment supports development of ICE catheter technologies for integration into Medtronic's Affera mapping and ablation system for cardiac ablation procedures.
- Orchestra BioMedstrategicCollaboration on BACKBEAT Global Pivotal Trial for hypertension treatment using Orchestra BioMed's technology. Enrollment targeted for Q3 2026. Partnership supports Medtronic's hypertension therapy platform expansion alongside Symplicity renal denervation system.
Scale indicators18 records
Recent moves6 records
Expansion highlights8 records
Medtronic competitors and assessment
Company assessmentDirect peers
- Intuitive Surgical: Direct competitor in surgical robotics via the da Vinci platform; competes head-to-head with Medtronic's Hugo RAS system for hospital capital equipment and recurring instrument revenue.
- Boston Scientific: Closest diversified medical device peer across cardiology, peripheral, endoscopy, and neuromodulation; competes directly with Medtronic in cardiac rhythm management, structural heart, and urology/pelvic health.
- Edwards Lifesciences: Direct competitor in structural heart (TAVR/surgical heart valves) and critical care monitoring; overlapping customers with Medtronic's cardiac surgery and surgical ICU portfolios.
- Zimmer Biomet: Orthopedic medical device peer overlapping with Medtronic's spine and cranial/skeletal franchises; competes in joint reconstruction, surgical robotics (Rosa), and enabling technologies for hospitals.
- Penumbra: Neurovascular thrombectomy and access products competitor; directly overlaps with Medtronic's neurovascular stroke portfolio, which was recently reinforced by the $550M Scientia Vascular acquisition.
Broad incumbents
- Johnson & Johnson (MedTech): Broad incumbent in medical devices through its MedTech franchise (Ethicon, DePuy Synthes, Cerenovus); overlaps with Medtronic in surgical robotics via Verb Surgical, spine, neurovascular, and electrophysiology.
- Stryker: Diversified medical device peer across orthopedics, surgical instruments, neurotechnology, and endoscopy; comparable global hospital sales motion and capital equipment model to Medtronic.
- Abbott Laboratories: Large medical device peer competing with Medtronic in cardiac rhythm management, structural heart, neuromodulation, and diabetes (FreeStyle Libre), and serves similar hospital channels.
- Becton, Dickinson and Company (BD): Large medical device and diagnostics company overlapping with Medtronic in surgical instruments, infection prevention, and acute care monitoring sold through similar hospital procurement channels.
- Baxter International: Diversified medical products peer with overlapping franchises in patient monitoring, surgical solutions, and hospital drug delivery; serves the same acute care hospital customers as Medtronic.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Medtronic social profiles
Digital presenceMedtronic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medtronic leadership team
Management profileNumber of profiles
Profiles18 records
Medtronic subsidiaries and ownership
Company hierarchySubsidiaries4 records
Medtronic funding detail
Funding detailFunding overview
Funding rounds11 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medtronic M&A and investment
M&A and investmentM&A76 records
Investments95 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medtronic
What does Medtronic do?
Medtronic designs, manufactures, and sells medical devices and capital equipment across cardiovascular, surgical robotics, neurovascular, neuromodulation, and diabetes therapy areas. Its portfolio includes robotic-assisted surgery systems (Hugo RAS), pulsed field ablation systems (PulseSelect), renal denervation systems (Symplicity Spyral), surgical navigation platforms (Stealth AXiS), pulse oximetry systems (Nellcor), and cardiac mapping/ablation systems (Affera), sold primarily to hospitals, healthcare systems, and ambulatory surgery centers worldwide.
Is Medtronic a public or private company?
Medtronic is a public company. It is classified as public and is currently operating.
When was Medtronic founded?
Medtronic was founded in 1949. It employs 5,001 to 10,000 people.
Where is Medtronic based?
Medtronic is headquartered in Minneapolis, United States, in the North America region.
How does Medtronic make money?
Four revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are diabetes Care Products, surgical Systems and Accessories and service and Support.
Who are Medtronic's main competitors?
Direct peers on record are Intuitive Surgical, Boston Scientific, Edwards Lifesciences, Zimmer Biomet and Penumbra. Broad incumbents are Johnson & Johnson (MedTech), Stryker, Abbott Laboratories, Becton, Dickinson and Company (BD) and Baxter International.
Does Medtronic have an API?
No public API is recorded for Medtronic.
What industry is Medtronic in?
Medtronic's product category is Medical Devices. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation). Its NAICS code is 339112 and its SIC code is 3841.